ASS1 and glioblastoma: In a mouse intracranial model, ADI-PEG20 effectively reduced peripheral blood arginine levels in as little as 48 h, significantly reduced intracranial growth and prolonged survival of GBM in ASS1-negative mice, and showed no significant toxic effects (Przystal et al., 2018).